TransMedics Group, Inc. (TMDX)

147.82 +3.16 (+2.18%) 收市：04:00PM EDT

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900
https://www.transmedics.com

版塊: Healthcare
行業: Medical Devices
全職員工: 584

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Waleed H. Hassanein M.D.	Founder, President, CEO & Director	1.82M	13.38M	1968
Mr. Stephen Gordon	CFO, Treasurer & Secretary	909.62k	1.31M	1968
Mr. Nicholas Corcoran	Senior Vice President of Supply Chain & Operations	812.07k	無	1983
Mr. Anil Ranganath	Senior VP, General Counsel & Corporate Secretary	561.67k	無	無
Dr. Tamer I. Khayal M.D.	Chief Commercial Officer	900.11k	5.45M	1969
Mr. Mark Anderson	Senior Director of Technology Development	無	無	無
Ms. Susan Goodman	Vice President of Human Resources	無	無	無
Ms. Miriam C. Provost Ph.D.	Vice President of Global Regulatory Affairs	535.93k	390.25k	1961

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

公司管治

截至 2024年6月1日 止，TransMedics Group, Inc. 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中：2；董事會：3；股東權利：3；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。